Corium Inc

Corium Inc. is a commercial-stage biopharmaceutical company headquartered in Kentwood, Michigan. The company employs 275 individuals and generates an annual revenue of $100 million. Corium focuses on the development and commercialization of central nervous system (CNS) healthcare therapies. These therapies aim to provide clinicians with effective treatment options for patients, their families, and caregivers who are dealing with various CNS-related conditions. With a proven history of success, Corium collaborates with prominent pharmaceutical and consumer product companies. The company's expertise spans the entire product lifecycle, from initial concept and development to manufacturing and final commercialization. For further information about Corium Inc. and its innovative CNS therapies, please visit their website at corium.com.